Post by sgard434 on Apr 26, 2017 21:18:18 GMT
It's that time again. Hints at Q1 '17 BRL earnings by looking at other lab companies as they report.
LH - LabCorp
Revenue: $2.45B Expected: $2.41B
EPS: $1.84/sh, adj.EPS (non-GAAP): $2.22 Expected: $2.2
2017 guidance:
net revenue growth 3.5% to 5.5%
EPS for yr $9.20 to $9.60 vs. previous estimate of $9.35 to $9.75
stock off 5.4% on the lowered revenue projection some of which is foreign currency related.
LH - LabCorp
Revenue: $2.45B Expected: $2.41B
EPS: $1.84/sh, adj.EPS (non-GAAP): $2.22 Expected: $2.2
2017 guidance:
net revenue growth 3.5% to 5.5%
EPS for yr $9.20 to $9.60 vs. previous estimate of $9.35 to $9.75
stock off 5.4% on the lowered revenue projection some of which is foreign currency related.
